Fragmentation of Stones by Burst Wave Lithotripsy in the First 19 Humans
- PMID: 35311351
- PMCID: PMC9078634
- DOI: 10.1097/JU.0000000000002446
Fragmentation of Stones by Burst Wave Lithotripsy in the First 19 Humans
Abstract
Purpose: We report stone comminution in the first 19 human subjects by burst wave lithotripsy (BWL), which is the transcutaneous application of focused, cyclic ultrasound pulses.
Materials and methods: This was a prospective multi-institutional feasibility study recruiting subjects undergoing clinical ureteroscopy (URS) for at least 1 stone ≤12 mm as measured on computerized tomography. During the planned URS, either before or after ureteroscope insertion, BWL was administered with a handheld transducer, and any stone fragmentation and tissue injury were observed. Up to 3 stones per subject were targeted, each for a maximum of 10 minutes. The primary effectiveness outcome was the volume percent comminution of the stone into fragments ≤2 mm. The primary safety outcome was the independent, blinded visual scoring of tissue injury from the URS video.
Results: Overall, median stone comminution was 90% (IQR 20, 100) of stone volume with 21 of 23 (91%) stones fragmented. Complete fragmentation (all fragments ≤2 mm) within 10 minutes of BWL occurred in 9 of 23 stones (39%). Of the 6 least comminuted stones, likely causative factors for decreased effectiveness included stones that were larger than the BWL beamwidth, smaller than the BWL wavelength or the introduction of air bubbles from the ureteroscope. Mild reddening of the papilla and hematuria emanating from the papilla were observed ureteroscopically.
Conclusions: The first study of BWL in human subjects resulted in a median of 90% comminution of the total stone volume into fragments ≤2 mm within 10 minutes of BWL exposure with only mild tissue injury.
Keywords: kidney calculi; lithotripsy; ultrasonography; ureteral calculi; ureteroscopy.
Conflict of interest statement
Conflict of Interest: RMS: CEO of Simagine Health, recipient of U.S. Department of Defense grants (current), recipient of AUA honorarium for course directorship (past). Authors Michael Bailey, Adam Maxwell, Barbrina Dunmire, Bryan Cunitz and Mathew Sorensen have equity in, and consulting agreements with, SonoMotion, Inc., which licensed the reported technology from the University of Washington for commercialization.
Figures
Comment in
-
Editorial Comment.J Urol. 2022 May;207(5):1075-1076. doi: 10.1097/JU.0000000000002446.02. Epub 2022 Mar 21. J Urol. 2022. PMID: 35311352 No abstract available.
References
-
- Litwin MS and Saigal CS: Table 14-47: economic impact of urologic disease. In: Urologic Diseases in America. US Department of Health and Human Services, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Public Health Service. Washington, DC: US Government Printing Office; 2012; NIH publication 12–7865.
-
- Kidney Stones 2017. In: Urologic Diseases in America. Edited by Feinstein L. US Department of Health and Human Services, Public Health Service, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases. Washington, DC: US Government Printing Office; 2018; NIH Publication 12–7865.
-
- Saigal CS, Joyce G, Timilsina AR et al.: Direct and indirect costs of nephrolithiasis in an employed population: opportunity for disease management? Kidney Int 2005; 68: 1808. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
